Literature DB >> 8308964

Autoantibodies in interstitial cystitis.

R L Ochs1, T W Stein, C L Peebles, R F Gittes, E M Tan.   

Abstract

We have identified and partially characterized autoantibodies from the sera of patients with interstitial cystitis. Our characterization included initial screening by antinuclear antibody testing on human HEp-2 cell substrate and mouse kidney/stomach tissue substrate, titering and subtyping of positive sera, and Western blotting to identify target autoantigens. Of 96 interstitial cystitis patients 35 (36%) were positive for antinuclear antibodies at titers of 1/40 or greater. Among the antinuclear antibody patterns observed 24 were dense fine nuclear speckles, 7 were nucleolar, 3 were mitochondrial and 1 was coarse nuclear speckles. All but 4 of the antinuclear antibody positive sera were exclusively of the IgG class. As determined by unique antinuclear antibody staining patterns and by specificities on Western blots, interstitial cystitis autoantibodies appear to recognize novel autoantigens not previously described in patients with systemic autoimmune diseases, such as lupus, scleroderma and Sjögren's syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8308964     DOI: 10.1016/s0022-5347(17)35023-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  35 in total

Review 1.  Sjögren's syndrome accompanied with interstitial cystitis: a case report and review of the literature.

Authors:  Dongfeng Liang; Jinshan Lu; Aitao Guo
Journal:  Clin Rheumatol       Date:  2014-01-07       Impact factor: 2.980

Review 2.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 3.  Interstitial cystitis: the painful bladder syndrome.

Authors:  R Doggweiler-Wiygul; J Blankenship; S A MacDiarmid
Journal:  Curr Rev Pain       Date:  2000

Review 4.  Interstitial cystitis.

Authors:  D R Erickson; M F Davies
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

5.  Clinical use of anti-DFS70 autoantibodies.

Authors:  So Young Kang; Woo In Lee; Myeong Hee Kim; You La Jeon
Journal:  Rheumatol Int       Date:  2019-04-10       Impact factor: 2.631

Review 6.  Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies.

Authors:  Anne E Tebo
Journal:  Clin Vaccine Immunol       Date:  2017-12-05

7.  Early termination of a trial of mycophenolate mofetil for treatment of interstitial cystitis/painful bladder syndrome: lessons learned.

Authors:  Claire C Yang; David A Burks; Kathleen J Propert; Robert D Mayer; Kenneth M Peters; J Curtis Nickel; Christopher K Payne; Mary P FitzGerald; Philip M Hanno; Toby C Chai; Karl J Kreder; Emily S Lukacz; Harris E Foster; Liyi Cen; J Richard Landis; John W Kusek; Leroy M Nyberg
Journal:  J Urol       Date:  2011-01-15       Impact factor: 7.450

Review 8.  Models of inflammation of the lower urinary tract.

Authors:  Dale E Bjorling; Zun-Yi Wang; Wade Bushman
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

Review 9.  Interstitial cystitis/bladder pain syndrome: The evolving landscape, animal models and future perspectives.

Authors:  Yoshiyuki Akiyama; Yi Luo; Philip M Hanno; Daichi Maeda; Yukio Homma
Journal:  Int J Urol       Date:  2020-04-04       Impact factor: 3.369

10.  RDP58 inhibits T cell-mediated bladder inflammation in an autoimmune cystitis model.

Authors:  Wujiang Liu; Barry R Deyoung; Xiaohong Chen; David P Evanoff; Yi Luo
Journal:  J Autoimmun       Date:  2007-12-26       Impact factor: 7.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.